Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China · Delayed Price · Currency is CNY 36.20
+0.16 (0.44%)
Aug 11, 2026, 12:54 PM CST
SHE:002294 Market Cap
SHE:002294 has a market cap or net worth of 40.18 billion as of August 10, 2026. Its market cap has decreased by -24.59% in one year.
Market Cap
40.18B
Enterprise Value
38.71B
Revenue
4.52B
Ranking
n/a
PE Ratio
60.03
Stock Price
36.20
ChartMarket Cap Chart
Since September 10, 2009, SHE:002294's market cap has increased from 5.64B to 40.18B, an increase of 612.41%. That is a compound annual growth rate of 12.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 40.18B | -27.27% |
| Dec 31, 2025 | 55.24B | 60.20% |
| Dec 31, 2024 | 34.48B | -3.26% |
| Dec 29, 2023 | 35.64B | -1.61% |
| Dec 30, 2022 | 36.23B | 19.87% |
| Dec 31, 2021 | 30.22B | 3.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Fosun Pharmaceutical (Group) | 57.77B |
| Huadong Medicine | 50.84B |
| China Resources Sanjiu Medical & Pharmaceutical | 41.82B |
| Beijing Tongrentang | 34.34B |
| Dong-E-E-Jiao | 34.08B |
| Changchun High-Tech Industry (Group) | 32.34B |
| Betta Pharmaceuticals | 29.54B |
| Humanwell Healthcare (Group) | 29.30B |